ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 36 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,249,000 | +29.3% | 3,380,000 | +15.2% | 0.62% | +88.7% |
| Q2 2017 | $2,513,000 | +18.3% | 2,935,000 | +16.7% | 0.33% | +3.8% |
| Q1 2017 | $2,125,000 | -75.0% | 2,515,000 | -77.5% | 0.32% | -75.4% |
| Q4 2016 | $8,512,000 | +32.2% | 11,200,000 | +41.8% | 1.28% | +35.3% |
| Q3 2016 | $6,439,000 | +73.4% | 7,900,000 | +85.9% | 0.95% | +65.0% |
| Q2 2016 | $3,713,000 | -29.2% | 4,250,000 | -6.6% | 0.58% | -25.9% |
| Q4 2015 | $5,243,000 | +8.4% | 4,550,000 | -14.9% | 0.78% | -2.9% |
| Q3 2015 | $4,837,000 | -40.6% | 5,345,000 | -33.6% | 0.80% | -36.0% |
| Q2 2015 | $8,147,000 | -25.1% | 8,050,000 | -24.4% | 1.25% | -21.4% |
| Q1 2015 | $10,877,000 | +71.8% | 10,650,000 | +93.6% | 1.59% | +57.0% |
| Q4 2014 | $6,332,000 | +23.0% | 5,500,000 | +10.0% | 1.01% | +28.1% |
| Q3 2014 | $5,150,000 | – | 5,000,000 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 8,750,000 | $6,650,000 | 3.76% |
| Mohican Financial Management, LLC | 3,000,000 | $2,280,000 | 2.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 11,200,000 | $8,512,000 | 1.28% |
| ANGELO GORDON & CO., L.P. | 22,500,000 | $17,100,000 | 1.26% |
| Context Capital Management, LLC | 1,500,000 | $1,140,000 | 1.25% |
| Opera Trading Capital | 4,500,000 | $3,400,000 | 1.02% |
| Jabre Capital Partners S.A. | 6,650,000 | $5,037,000 | 0.58% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $4,576,000 | 0.44% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 28,000,000 | $21,345,000,000 | 0.41% |
| Man Investments (CH) AG | 700,000 | $536,000 | 0.31% |